BioGaia AB (publ) (STO: BIOG.B)

Market Cap	12.21B
Revenue (ttm)	1.37B
Net Income (ttm)	401.72M
Shares Out	101.16M
EPS (ttm)	3.98
PE Ratio	30.34
Forward PE	34.88
Dividend	6.90 (5.72%)
Ex-Dividend Date	May 8, 2024

Volume	191,017
Open	119.20
Previous Close	118.50
Day's Range	118.50 - 122.50
52-Week Range	91.45 - 136.60
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 12, 2025

About BioGaia AB

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its pro...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 210
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOG.B

Financial Performance

In 2023, BioGaia AB's revenue was 1.30 billion, an increase of 17.44% compared to the previous year's 1.10 billion. Earnings were 365.35 million, a decrease of -2.25%.